We performed a thorough immunohistochemical analysis on post-tumor tissues from simultaneous versus sequential treatments involving CD3, CD4, CD8 (as illustrated in Figure 6A), CD11b, CD163, CD204 (as illustrated in Figure 6B), and PD1, PD-L1 (as illustrated in Supplementary Figure S4). The gene discussed is RPL17; the disease is neoplasm.